4DMEDICAL
- Company typePublic
- Founded2012
- HeadquartersMelbourne, Australia
- Headcount101–250
- GTM typeB2B
- OfferingSoftware
4DMEDICAL firmographics
Firmographics- Name
- 4DMEDICAL
- Legal name
- 4DMedical Limited
- Website
- https://4dmedical.com
- Company type
- Public
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Ownership category
- akta.pro rank
4DMEDICAL industry classification
Industry- Product category
- Medical Imaging Software
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391), Scientific Research and Development Services (5417)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Radiology AI, CAD & Advanced Visualization Software (HLAHABAJ)
- akta.pro secondary industries
- AI Orchestration & Imaging Analytics Platforms (Model Management/Triage) (HLACALAG), Medical Imaging AI (HDAAAEAH)
Keywords
Where 4DMEDICAL is headquartered
LocationHeadquarters
- HQ city
- Melbourne
- HQ country
- Australia
- HQ region
- Oceania
Offices4 records
Markets served
4DMEDICAL business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Others
Revenue model
- Per-scan SaaS / Usage-based Software: Cloud-based SaaS model with per-scan pricing. Commercial agreements with SimonMed Imaging and other health systems on per-scan commercial terms. Revenue recognized per scan processed through the platform.
- Software Licenses and Subscriptions: Enterprise software licensing model for hospital deployments. Minimum order commitments from partners (e.g., Philips $10M minimum for 2026-2027).
- Biopharma Research Services: Contract research services for pulmonary drug development. One-year GSK contract for quantitative lung imaging analytics supporting clinical research.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Usage-based | Pay-as-you-go | Per-scan SaaS pricing for CT:VQ and LDAf deployments |
Go-to-market motion4 records
Distribution channels5 records
Marketing channels6 records
4DMEDICAL product offering
Product offeringCore offering
4DMedical develops and sells AI-driven functional lung imaging software that converts routine chest CT scans and X-ray fluoroscopy into quantitative ventilation and perfusion maps, lung density analyses, and pulmonary disease diagnostic outputs. Its flagship products — CT:VQ (the first FDA-cleared non-contrast V/Q imaging solution) and XV LVAS (X-ray Velocimetry) — are sold as cloud SaaS to hospitals, outpatient imaging centers, biopharma, and government health customers. The company also distributes the XV Scanner hardware device for clinical research use and offers the Imbio and contextflow cardiothoracic and chest CT AI suites acquired in 2023 and 2026.
Product overview
4DMedical is a medical technology company offering a comprehensive cardiothoracic imaging software platform with both proprietary XV Technology and Imbio Technology. The portfolio centers on CT:VQ (FDA-cleared non-contrast ventilation-perfusion imaging) and XV LVAS (X-ray velocimetry-based lung ventilation analysis), complemented by a suite of specialized lung analysis modules including CT LVAS, LDAf, LDAi, IQ-UIP (AI-driven UIP detection), LTA, PHA, and CAC. The company also acquired Imbio (2023) and contextflow (2026) to expand capabilities and establish European commercial presence. All products are delivered as cloud-based SaaS software that analyzes routine CT or X-ray scans to provide quantitative functional lung insights without requiring additional specialized equipment.
Differentiator
Problem solved
Functional benefit
Brands
- Imbio: Medical imaging analysis technologies including CAC, IQ-UIP, LDA, LTA, PHA products for cardiothoracic imaging. A fully owned subsidiary and retained brand following acquisition in December 2023.
- CT:VQ
- XV Technology
- contextflow
Products and services
- CT:VQ — Non-Contrast Ventilation-Perfusion Imaging World's first and only FDA-cleared, CE-marked and Health Canada-cleared non-contrast ventilation-perfusion imaging software that converts routine chest CT scans into quantitative V/Q maps for functional lung assessment without radiotracers or nuclear medicine infrastructure. Used by hospitals, outpatient imaging centers, biopharma and government health customers.
- XV LVAS — X-ray Velocimetry Lung Ventilation Analysis Software Creates moving 4D images during X-ray fluoroscopy exams and uses machine-learning algorithms adapted from aerospace wind tunnel processing to quantitatively measure regional lung ventilation and produce color-coded ventilation maps. Sold to hospitals, clinical researchers, and veteran health providers.
- CT LVAS — CT Lung Ventilation Analysis Software Provides quantitative lung ventilation analysis from standard chest CT scans, validated against the gold standard PET method in peer-reviewed publications. Used by clinical imaging departments and research centers for regional lung function assessment.
- IQ-UIP — Early IPF Detection AI-driven diagnostic software that detects the Usual Interstitial Pneumonia (UIP) pattern from CT scans, the hallmark radiological pattern for diagnosing Idiopathic Pulmonary Fibrosis (IPF). FDA 510(k) cleared and intended for radiologists and pulmonologists.
- CAC — Coronary Artery Calcification Software AI-powered automated coronary artery calcium scoring from routine chest CT scans for cardiovascular risk assessment. Part of the Imbio imaging suite used by hospitals and imaging centers.
- LDAf — Functional Lung Density Analysis
Quantifiable outcome
- First and only non-contrast V/Q imaging solution with FDA 510(k) clearance
- +3 more outcomes
Companies that use 4DMEDICAL
Customer profileNamed customers11 records
Segments5 records
Ideal customer profiles4 records
4DMEDICAL technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature8 records
4DMEDICAL partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- contextflow GmbHcoreBinding agreement to acquire Vienna-based medical imaging software company specializing in lung cancer detection, chest CT analysis, and radiology workflow solutions. All-share transaction with cash, shares, and performance-based options. Establishes 4DMedical's European commercial platform with CE-marked products, existing customer base, and MDR-aligned regulatory capabilities. CEO Markus Holzer becomes General Manager of Europe.
- SimonMed ImagingcoreThree-year commercial agreement for deployment of CT:VQ and LDAf across SimonMed's network of 170+ outpatient imaging centers in 10 U.S. states. Per-scan pricing with immediate commercial effect. SimonMed will support development of reimbursement evidence for CT:VQ across public and private payors.
- GSK (GlaxoSmithKline)coreOne-year contract commencing May 2026 to provide quantitative lung imaging analytics to support pulmonary drug development and clinical research. Partnership includes Flywheel Exchange for data management. Validates growing biopharma demand for 4DMedical's imaging platform.
- PhilipscorePhilips distributes 4DMedical's CT:VQ across healthcare systems in U.S. and Canada through its Advanced Visualization Workspace (AVW) on HealthSuite cloud platform powered by AWS. Expanded partnership with minimum US$10 million order commitment for 2026-2027. Also featured as AI partnership at RSNA 2025 for pulmonary conditions.
- Blackford AnalysisminorDistribution agreement for Imbio's medical imaging AI solutions. Blackford distributes Imbio's imaging analysis software to healthcare customers.
- Adelaide University and University of MelbourneminorResearch collaboration with Australian universities for X-ray velocimetry (XV) technology development. Project funded by Australia's Economic Accelerator to advance AI-driven functional lung imaging for cystic fibrosis, asthma, and bronchiectasis detection.
Scale indicators10 records
Recent moves7 records
Expansion highlights6 records
4DMEDICAL competitors and assessment
Company assessmentDirect peers
- contextflow: Vienna-based AI radiology company specializing in lung CT pattern recognition, nodule detection, and radiology workflow. Direct comparable to 4DMedical's lung CT analytics franchise and is being acquired by 4DMedical to anchor its European platform.
- Riverain Technologies: AI imaging vendor focused on chest CT and X-ray analysis for lung nodule detection, lung cancer screening, and chest radiology workflow. Closely comparable to 4DMedical's lung-focused AI radiology software portfolio targeting radiologists and pulmonologists.
- Optellum: AI platform for lung cancer detection, lung nodule management, and pulmonary decision support from CT imaging. Directly comparable to 4DMedical's lung cancer/CT analytics roadmap (especially via contextflow) and serves a similar pulmonologist/radiologist audience.
- Arterys (Tempus AI): Cloud-native AI imaging platform with FDA-cleared lung and cardiac analysis tools distributed via major PACS vendors. Comparable to 4DMedical's cloud-based, SaaS-delivered functional imaging model and its channel-led go-to-market.
Emerging players
- Aidoc: Broad radiology AI platform covering multiple body parts and modalities with enterprise hospital sales. Comparable to 4DMedical's enterprise SaaS model and per-study AI analytics, though Aidoc is more multi-organ rather than lung-specialized.
- Quibim: AI imaging analytics company offering quantitative imaging biomarkers across oncology, neurology, and chest imaging. Overlaps with 4DMedical's quantitative lung imaging and biopharma imaging biomarker use cases, particularly for clinical trial endpoints.
- Annalise.ai: Radiology AI suite with chest X-ray and CT modules covering multiple findings including lung pathology. Comparable to 4DMedical on the AI chest imaging product axis and on selling AI modules into hospital radiology workflows.
Broad incumbents
- Philips: Global medical imaging OEM with the Advanced Visualization Workspace that distributes 4DMedical's CT:VQ. Functions as both key channel partner and broad incumbent competitor in radiology AI and advanced visualization.
- GE HealthCare: Global imaging OEM (CT, X-ray, PACS) and developer of Edison AI radiology applications including lung/chest solutions. Comparable to 4DMedical as a broad incumbent in the same customer base of radiology departments and imaging centers.
- Siemens Healthineers: Imaging OEM with AI-Rad Companion and syngo.via advanced visualization, including chest CT and lung analysis tools. Comparable to 4DMedical in targeting radiology and pulmonology with embedded and standalone AI imaging software.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
4DMEDICAL social profiles
Digital presence4DMEDICAL compliance and trust
Trust signalCompliance6 records
4DMEDICAL financial estimates
Financial estimateRevenue estimate
Valuation estimate
4DMEDICAL leadership team
Management profileNumber of profiles
Profiles5 records
4DMEDICAL subsidiaries and ownership
Company hierarchySubsidiaries5 records
4DMEDICAL funding detail
Funding detailFunding overview
Funding rounds4 records
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
4DMEDICAL M&A and investment
M&A and investmentM&A2 records
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about 4DMEDICAL
What does 4DMEDICAL do?
4DMedical develops and sells AI-driven functional lung imaging software that converts routine chest CT scans and X-ray fluoroscopy into quantitative ventilation and perfusion maps, lung density analyses, and pulmonary disease diagnostic outputs. Its flagship products — CT:VQ (the first FDA-cleared non-contrast V/Q imaging solution) and XV LVAS (X-ray Velocimetry) — are sold as cloud SaaS to hospitals, outpatient imaging centers, biopharma, and government health customers. The company also distributes the XV Scanner hardware device for clinical research use and offers the Imbio and contextflow cardiothoracic and chest CT AI suites acquired in 2023 and 2026.
Is 4DMEDICAL a public or private company?
4DMEDICAL is a public company. It is classified as public and is currently operating.
When was 4DMEDICAL founded?
4DMEDICAL was founded in 2012. It employs 101 to 250 people.
Where is 4DMEDICAL based?
4DMEDICAL is headquartered in Melbourne, Australia, in the Oceania region.
How does 4DMEDICAL make money?
Three revenue lines are on record. Per-scan SaaS / Usage-based Software is the primary driver. The others are software Licenses and Subscriptions and biopharma Research Services.
Who are 4DMEDICAL's main competitors?
Direct peers on record are contextflow, Riverain Technologies, Optellum and Arterys (Tempus AI). Emerging players are Aidoc, Quibim and Annalise.ai. Broad incumbents are Philips, GE HealthCare and Siemens Healthineers.
Does 4DMEDICAL have an API?
No public API is recorded for 4DMEDICAL.
What industry is 4DMEDICAL in?
4DMEDICAL's product category is Medical Imaging Software. Its primary akta.pro industry code is HLAHABAJ, Radiology AI, CAD & Advanced Visualization Software, with a secondary code of HLACALAG, AI Orchestration & Imaging Analytics Platforms (Model Management/Triage). Its NAICS code is 339112 and its SIC code is 3841.